US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma.
Edward Robert Scheffer CliffDavid A Russler-GermainC Joseph Ross DavalAaron S KesselheimPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
The FDA's directive to deal with delayed confirmatory trials: lessons from pralatrexate and belinostat for T-cell lymphoma.